Enzo Biochem Inc financial data

Symbol
ENZB on OTC, ENZ on NYSE
Location
60 Executive Blvd, Farmingdale, NY
Fiscal year end
July 31
Latest financial report
10-Q - Q1 2025 - Jun 16, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 279 % -5.72%
Quick Ratio 30.3 % +14.3%
Debt-to-equity 50.7 % +15.8%
Return On Equity -43.5 % -171%
Return On Assets -28.9 % -168%
Operating Margin -41 % +19.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.4M shares +1.84%
Common Stock, Shares, Outstanding 52.4M shares +2.29%
Entity Public Float 57.5M USD +1.97%
Common Stock, Value, Issued 523K USD +2.35%
Weighted Average Number of Shares Outstanding, Basic 52.4K shares +2.32%
Weighted Average Number of Shares Outstanding, Diluted 52.4K shares +2.32%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 27.5M USD -17.6%
Cost of Revenue 3.76M USD -12.5%
Research and Development Expense 2.15M USD -33.3%
Operating Income (Loss) -11.3M USD +33.3%
Nonoperating Income (Expense) 1.02M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.84M USD +55.3%
Net Income (Loss) Attributable to Parent -21.1M USD -147%
Earnings Per Share, Basic 0 USD/shares -145%
Earnings Per Share, Diluted 0 USD/shares -145%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 36.7M USD -35.8%
Accounts Receivable, after Allowance for Credit Loss, Current 4.31M USD +9.5%
Inventory, Net 5.71M USD -22%
Assets, Current 48.3M USD -36.3%
Property, Plant and Equipment, Net 12.4M USD -2.04%
Operating Lease, Right-of-Use Asset 2.47M USD -16.5%
Goodwill 7.45M USD 0%
Other Assets, Noncurrent 481K USD -33.7%
Assets 63.5M USD -32%
Accrued Liabilities, Current 5.17M USD -3.83%
Liabilities, Current 17M USD -21.5%
Operating Lease, Liability, Noncurrent 1.92M USD -26%
Liabilities 20.1M USD -17.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.67M USD -33.1%
Retained Earnings (Accumulated Deficit) -302M USD -7.5%
Stockholders' Equity Attributable to Parent 43.4M USD -37.1%
Liabilities and Equity 63.5M USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.99M USD +32.8%
Net Cash Provided by (Used in) Financing Activities -200K USD +61.4%
Net Cash Provided by (Used in) Investing Activities 4.55M USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 52.4M shares +2.29%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.64M USD +67.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 36.7M USD -35.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -97.8%
Deferred Tax Assets, Valuation Allowance 29.7M USD +11.2%
Deferred Tax Assets, Gross 31.1M USD +3.8%
Operating Lease, Liability 2.8M USD -17.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.9M USD -149%
Lessee, Operating Lease, Liability, to be Paid 3.02M USD -19.5%
Property, Plant and Equipment, Gross 27.1M USD -4.26%
Operating Lease, Liability, Current 881K USD +10.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 907K USD +2.37%
Lessee, Operating Lease, Liability, to be Paid, Year One 989K USD +10.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 218K USD -38.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 833K USD -5.45%
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 43K USD -94.7%
Additional Paid in Capital 343M USD -1.08%
Depreciation, Depletion and Amortization 319K USD +18.1%
Deferred Tax Assets, Net of Valuation Allowance 29.7M USD +11.2%
Share-based Payment Arrangement, Expense 174K USD -15.9%
Interest Expense -1.38M USD -2117%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%